)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Amedisys
Amedisys (AMED) investor relations material
Amedisys has been acquired by UnitedHealth Group Incorporated
Amedisys Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary29 Jul, 2025
Executive summary
Net service revenue grew 5% year-over-year to $621.9M in Q2 2025, with adjusted EBITDA up 10% to $80.8M and adjusted EPS rising to $1.54.
Net income for Q2 2025 was $28.1M, including $26.3M in merger-related expenses; six-month net income was $89.1M, including $43M in merger costs and a $48.1M gain on equity investment.
Home Health and Hospice segments saw revenue and volume growth, with Home Health revenue at $396.2M and Hospice at $215.0M.
The company is in the process of merging with UnitedHealth Group, facing DOJ litigation and regulatory hurdles, with trial set for October 2025.
High Acuity Care admissions rose 29%, but the segment continued to generate operating losses.
Financial highlights
Adjusted EBITDA margin improved to 13.0% from 12.4% year-over-year; gross margin slightly declined to 44.3%.
Q2 2025 net income per diluted share was $0.84, down from $0.98 year-over-year; adjusted net income per diluted share was $1.54, up from $1.32.
Operating cash flow was $67.2M, reflecting strong receivables collection.
Free cash flow increased to $56.7M, and net leverage remained low at 0.1x.
Days sales outstanding improved to 40.9, down from 52.1 a year ago.
Outlook and guidance
CMS finalized a 2.9% hospice payment increase for FY 2025 and proposed a 2.4% increase for FY 2026.
CMS finalized a 0.5% home health payment increase for CY 2025 but proposed a 6.4% decrease for CY 2026.
Management expects continued operating losses in high acuity care but anticipates improvement as the segment scales.
Forward-looking statements highlight risks related to the pending merger, regulatory approvals, and transaction costs.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Amedisys
- Revenue up 6% to $588M; Home Health admissions +12%; merger costs weigh on income.AMED
Q3 2024 - Revenue and net income rose, merger pending, cash flow affected by billing delays.AMEDQ2 2024
- Revenue and profit grew, aided by a $48.1M equity gain, with merger and inflation risks highlighted.AMEDQ1 2025
- Revenue and adjusted earnings rose, but Q4 net loss stemmed from merger and impairment costs.AMEDQ4 2024
Amedisys
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Amedisys Inc is a healthcare services company that provides home health, hospice, and high-acuity care services. The company delivers clinical services to patients in their homes, including skilled nursing, physical therapy, and chronic disease management. Its hospice division offers palliative and end-of-life care, addressing the medical, emotional, and spiritual needs of patients and their families. Amedisys also provides hospital-at-home and skilled nursing facility-at-home programs through its high-acuity care segment. Amedisys Inc is headquartered in Baton Rouge, Louisiana, and its shares are listed on the NASDAQ.